14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IXC.AX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Invex Therapeutics Ltd stock price down 0% on Friday
(Updated on May 17, 2024)

Hold candidate since May 15, 2024 PDF

No changes to the price of Invex Therapeutics Ltd stock on the last trading day (Friday, 17th May 2024). During the last trading day the stock fluctuated 0% from a day low at $0.0760 to a day high of $0.0760. The price has been going up and down for this period, and there has been a -5% loss for the last 2 weeks.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -13.05% during the next 3 months and, with a 90% probability hold a price between $0.0592 and $0.0758 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IXC.AX Signals & Forecast

There are mixed signals in the stock today. The Invex Therapeutics Ltd stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0766 and $0.0827. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Monday, May 13, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Invex Therapeutics Ltd stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $0.0713 (-6.20%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 4 days ago.)

Trading Expectations (IXC.AX) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Invex Therapeutics Ltd to open at $0.0760, and during the day (based on 14 day Average True Range), to move between $0.0741 and $0.0779, which gives a possible trading interval of +/-$0.0019 (+/-2.54%) up or down from last closing price. If Invex Therapeutics Ltd takes out the full calculated possible swing range there will be an estimated 5.09% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.0810, some $0.0050 (6.58%) from the current price of $0.0760, our system finds the risk reward not very attractive.

Is Invex Therapeutics Ltd stock A Buy?

Invex Therapeutics Ltd holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Invex Therapeutics Ltd of Monday, May 20, 2024

Fair opening price May 20, 2024 Current price
$0.0760 ( 0%) $0.0760

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IXC.AX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0760 .
R2 0.0760 .
R1 0.0760 .
Current price: 0.0760
Support S1 0.0760 .
S2 0.0760 .
S3 0.0760 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0830 9.21 %
R2 0.0820 7.89 %
R1 0.0810 6.58 %
Current price 0.0760
Support S1 0 .
S2 0 .
S3 0 .

IXC Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Dec 08, 2023 Dec 08, 2023 Dec 08, 2023 $0 0%

FAQ

What is the symbol for Invex Therapeutics Ltd Stock and on which exchange is it traded?
The symbol for Invex Therapeutics Ltd is IXC.AX and it is traded on the ASX (Australian Securities Exchange).

Should I buy or sell Invex Therapeutics Ltd Stock?
Invex Therapeutics Ltd holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Invex Therapeutics Ltd Stock?
Invex Therapeutics Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Invex Therapeutics Ltd Stock.

What's the current price of Invex Therapeutics Ltd Stock?
As of the end of day on the May 17, 2024, the price of an Invex Therapeutics Ltd (IXC.AX) share was $0.0760.

What is the 52-week high and low for Invex Therapeutics Ltd Stock?
The 52-week high for Invex Therapeutics Ltd Stock is $0.630 and the 52-week low is $0.0600.

What is the market capitalization of Invex Therapeutics Ltd Stock?
As of the May 17, 2024, the market capitalization of Invex Therapeutics Ltd is 5.712M.

When is the next earnings date for Invex Therapeutics Ltd?
The upcoming earnings date for Invex Therapeutics Ltd is Aug 15, 2024.
Click to get the best stock tips daily for free!

About Invex Therapeutics Ltd

Invex Therapeutics Ltd Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury that has completed Phase II clinical trial. The company was incorporated in 20... IXC.AX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT